It has been 5 years since the launch of ‘Herceptin’… a targeted agent for stomach cancer will come out
It is expected that a new targeted agent will be launched since the launch of ‘Herceptin’ 5 years ago.
According to the industry concerned on the 28th, Lilly Korea is following procedures to acquire permission of the advanced stomach cancer and gastroesophageal junction adenocarcinoma treatment ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
